Postpartum Reclassification of Glycemic Status in Women with Gestational Diabetes Mellitus and Associated Risk Factors

 

 Permissions and Reprints

Abstract

Objective The aims of the study were to evaluate, after pregnancy, the glycemic status of women with history of gestational diabetes mellitus (GDM) and to identify clinical variables associated with the development of type 2 diabetes mellitus (T2DM), impaired fasting glucose (IFG), and impaired glucose tolerance (IGT).

Methods Retrospective cohort of 279 women with GDM who were reevaluated with an oral glucose tolerance test (OGTT) after pregnancy. Characteristics of the index pregnancy were analyzed as risk factors for the future development of prediabetes (IFG or IGT), and T2DM. Results: T2DM was diagnosed in 34 (12.2%) patients, IFG in 58 (20.8%), and IGT in 35 (12.5%). Women with postpartum T2DM showed more frequently a family history of T2DM, higher pre-pregnancy body mass index (BMI), lower gestational age, higher fasting and 2-hour plasma glucose levels on the OGTT at the diagnosis of GDM, higher levels of hemoglobin A1c, and a more frequent insulin requirement during pregnancy. Paternal history of T2DM (odds ratio [OR] = 5.67; 95% confidence interval [95%CI] = 1.64–19.59; p = 0.006), first trimester fasting glucose value (OR = 1.07; 95%CI = 1.03–1.11; p = 0.001), and insulin treatment during pregnancy (OR = 15.92; 95%CI = 5.54–45.71; p < 0.001) were significant independent risk factors for the development of T2DM.

Conclusion A high rate of abnormal glucose tolerance was found in women with previous GDM. Family history of T2DM, higher pre-pregnancy BMI, early onset of GDM, higher glucose levels, and insulin requirement during pregnancy were important risk factors for the early identification of women at high risk of developing T2DM. These findings may be useful for developing preventive strategies.

Resumo

Objetivo Os objetivos do estudo foram avaliar o estado glicêmico de mulheres com história de diabetes mellitus gestacional (DMG) após o parto e identificar fatores associados ao desenvolvimento de diabetes mellitus tipo 2 (DM2), glicemia de jejum alterada (GJA) e tolerância diminuída à glicose (TDG).

Métodos Coorte retrospectiva de 279 mulheres com DMG reavaliadas com um teste oral de tolerância à glicose (TOTG) após a gestação. Foram analisados fatores prognósticos da gestação índice e fatores de risco para o futuro desenvolvimento de pré-diabetes (GJA ou TDG) e DM2. Resultados: Diagnosticou-se DM2 em 34 pacientes (12,2%), GJA em 58 (20,8%) e TDG em 35 (12,5%). Mulheres que evoluíram para DM2 apresentaram maior frequência de história familiar de DM2, índice de massa corporal (IMC) pré-gestacional mais elevado, menor idade gestacional, níveis superiores de glicemia de jejum e 2 horas após glicose no TOTG ao diagnóstico do DMG, hemoglobina glicada mais elevada, e uso mais frequente de insulina na gestação. História paterna de DM2 (odds ratio [OR] = 5,67; intervalo de confiança de 95% [IC95%] = 1,64–19,59; p = 0,006), glicemia de jejum do primeiro trimestre (OR = 1,07; IC95% = 1,03–1,11; p = 0,001) e o uso de insulina na gestação (OR = 15,92; IC95% = 5,54–45,71; p < 0,001) foram fatores de risco independentes para o desenvolvimento de DM2.

Conclusão Houve elevada incidência de alterações no metabolismo da glicose em mulheres com DMG prévio. História familiar de DM2, IMC pré-gestacional elevado, DMG diagnosticado mais precocemente na gestação, com glicemias mais elevadas e necessidade de insulina, foram importantes fatores de risco associados à identificação precoce de mulheres com alto risco de desenvolvimento de DM2. Este conhecimento pode ser útil para o desenvolvimento de estratégias de prevenção.

• References

• 1 National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28 (12) 1039-1057
  CrossrefPubMedGoogle Scholar
• 2 Metzger BE, Lowe LP, Dyer AR , et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358 (19) 1991-2002
  CrossrefPubMedGoogle Scholar
• 3 Metzger BE, Gabbe SG, Persson B , et al; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33 (3) 676-682
  Google Scholar
• 4 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36 (Suppl. 01) S67-S74
  CrossrefPubMedGoogle Scholar
• 5 Sacks DA, Hadden DR, Maresh M , et al; HAPO Study Cooperative Research Group. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012; 35 (3) 526-528
  CrossrefPubMedGoogle Scholar
• 6 Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014; 103 (2) 176-185
  CrossrefPubMedGoogle Scholar
• 7 Trujillo J, Vigo A, Duncan BB , et al. Impact of the International Association of Diabetes and Pregnancy Study Groups criteria for gestational diabetes. Diabetes Res Clin Pract 2015; 108 (2) 288-295
  CrossrefPubMedGoogle Scholar
• 8 Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373 (9677) 1773-1779
  CrossrefPubMedGoogle Scholar
• 9 Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25 (10) 1862-1868
  CrossrefPubMedGoogle Scholar
• 10 American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care 2011; 34 (Suppl. 01) S11-S61
  CrossrefPubMedGoogle Scholar
• 11 Ratner RE, Christophi CA, Metzger BE , et al; Diabetes Prevention Program Research Group. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008; 93 (12) 4774-4779
  CrossrefPubMedGoogle Scholar
• 12 Aroda VR, Christophi CA, Edelstein SL , et al; Diabetes Prevention Program Research Group. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab 2015; 100 (4) 1646-1653
  CrossrefPubMedGoogle Scholar
• 13 Reichelt AJ, Oppermann MLR, Schmidt MI. Recomendações da 2.ª reunião de grupo de trabalho em diabetes e gravidez. Arq Bras Endocrinol Metabol 2002; 46 (5) 574-581
  CrossrefPubMedGoogle Scholar
• 14 Institute of Medicine. National Research Council. Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight gain during pregnancy: reexamining the guidelines. Washington (DC): The National Academies Press; 2009
  Google Scholar
• 15 Jacob Reichelt AA, Ferraz TM, Rocha Oppermann ML , et al. Detecting glucose intolerance after gestational diabetes: inadequacy of fasting glucose alone and risk associated with gestational diabetes and second trimester waist-hip ratio. Diabetologia 2002; 45 (3) 455-457
  CrossrefPubMedGoogle Scholar
• 16 Silva MRG, Calderon IdeM, Gonçalves LC, Aragon FF, Padovani CR, Pimenta WdeP. Occurrence of diabetes mellitus in women with prior gestational hyperglycemia. Rev Saude Publica 2003; 37 (3) 345-350
  CrossrefPubMedGoogle Scholar
• 17 Sivaraman SC, Vinnamala S, Jenkins D. Gestational diabetes and future risk of diabetes. J Clin Med Res 2013; 5 (2) 92-96
  PubMedGoogle Scholar
• 18 Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 1995; 44 (5) 586-591
  CrossrefPubMedGoogle Scholar
• 19 Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 1991; 165 (4 Pt 1): 914-919
  CrossrefPubMedGoogle Scholar
• 20 Lam KS, Li DF, Lauder IJ, Lee CP, Kung AW, Ma JT. Prediction of persistent carbohydrate intolerance in patients with gestational diabetes. Diabetes Res Clin Pract 1991; 12 (3) 181-186
  CrossrefPubMedGoogle Scholar
• 21 Steinhart JR, Sugarman JR, Connell FA. Gestational diabetes is a herald of NIDDM in Navajo women. High rate of abnormal glucose tolerance after GDM. Diabetes Care 1997; 20 (6) 943-947
  CrossrefPubMedGoogle Scholar
• 22 Bartha JL, Martinez-del-Fresno P, Comino-Delgado R. Postpartum metabolism and autoantibody markers in women with gestational diabetes mellitus diagnosed in early pregnancy. Am J Obstet Gynecol 2001; 184 (5) 965-970
  CrossrefPubMedGoogle Scholar
• 23 Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL. Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 2002; 186 (4) 751-756
  CrossrefPubMedGoogle Scholar
• 24 Coustan DR, Carpenter MW, O'Sullivan PS, Carr SR. Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol 1993; 168 (4) 1139-1144 , discussion 1144–1145
  CrossrefPubMedGoogle Scholar
• 25 Ekelund M, Shaat N, Almgren P, Groop L, Berntorp K. Prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetologia 2010; 53 (3) 452-457
  CrossrefPubMedGoogle Scholar
• 26 Weinert LS, Mastella LS, Oppermann ML, Silveiro SP, Guimarães LS, Reichelt AJ. Postpartum glucose tolerance status 6 to 12 weeks after gestational diabetes mellitus: a Brazilian cohort. Arq Bras Endocrinol Metabol 2014; 58 (2) 197-204
  CrossrefPubMedGoogle Scholar
• 27 Chew WF, Rokiah P, Chan SP, Chee WS, Lee LF, Chan YM. Prevalence of glucose intolerance, and associated antenatal and historical risk factors among Malaysian women with a history of gestational diabetes mellitus. Singapore Med J 2012; 53 (12) 814-820
  PubMedGoogle Scholar
• 28 Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK. Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes 1999; 48 (12) 2430-2436
  CrossrefPubMedGoogle Scholar
• 29 Kwak SH, Choi SH, Jung HS , et al. Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J Clin Endocrinol Metab 2013; 98 (4) E744-E752
  CrossrefPubMedGoogle Scholar
• 30 Feig DS, Zinman B, Wang X, Hux JE. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 2008; 179 (3) 229-234
  CrossrefPubMedGoogle Scholar
• 31 Aberg AE, Jönsson EK, Eskilsson I, Landin-Olsson M, Frid AH. Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand 2002; 81 (1) 11-16
  CrossrefPubMedGoogle Scholar
• 32 Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 2007; 30 (4) 878-883
  CrossrefPubMedGoogle Scholar
• 33 Stasenko M, Cheng YW, McLean T, Jelin AC, Rand L, Caughey AB. Postpartum follow-up for women with gestational diabetes mellitus. Am J Perinatol 2010; 27 (9) 737-742
  Article in Thieme ConnectPubMedGoogle Scholar
• 34 Lawrence JM, Black MH, Hsu JW, Chen W, Sacks DA. Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care 2010; 33 (3) 569-576
  CrossrefPubMedGoogle Scholar
• 35 Ferrara A, Peng T, Kim C. Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2009; 32 (2) 269-274
  CrossrefPubMedGoogle Scholar
• 36 Ogonowski J, Miazgowski T. The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res Clin Pract 2009; 84 (3) 239-244
  CrossrefPubMedGoogle Scholar
• 37 Almario CV, Ecker T, Moroz LA, Bucovetsky L, Berghella V, Baxter JK. Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am J Obstet Gynecol 2008; 198 (5) 528.e1-528.e5
  CrossrefPubMedGoogle Scholar
• 38 McGovern A, Butler L, Jones S , et al. Diabetes screening after gestational diabetes in England: a quantitative retrospective cohort study. Br J Gen Pract 2014; 64 (618) e17-e23
  CrossrefPubMedGoogle Scholar
• 39 Tovar A, Chasan-Taber L, Eggleston E, Oken E. Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis 2011; 8 (6) A124
  PubMedGoogle Scholar
• 40 Morrison MK, Collins CE, Lowe JM. Postnatal testing for diabetes in Australian women following gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 2009; 49 (5) 494-498
  CrossrefPubMedGoogle Scholar
• 41 World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: WHO; 1999
  Google Scholar
• 42 Buchanan TA, Xiang AH, Peters RK , et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002; 51 (9) 2796-2803
  CrossrefPubMedGoogle Scholar